Last10K.com

Mckesson Corp (MCK) SEC Filing 10-Q Quarterly Report for the period ending Wednesday, June 30, 2021

Mckesson Corp

CIK: 927653 Ticker: MCK

Exhibit 99.1


mckessonlogoa03.jpg


McKESSON REPORTS FISCAL 2022 FIRST-QUARTER RESULTS

First-Quarter Highlights, Year-over-Year:
Total revenues of $62.7 billion increased 13%
Earnings per diluted share from continuing operations of $3.09 increased 14%
Adjusted Earnings per diluted share of $5.56 increased 101%
Board of Directors increased the quarterly dividend by 12% to $0.47 per share

Fiscal 2022 Outlook:
Increased fiscal 2022 Adjusted Earnings per diluted share guidance range to $19.80 to $20.40, from the previous range of $18.85 to $19.45, representing 15% to 18.5% growth year-over-year
Guidance assumes $0.80 to $1.00 of Adjusted Earnings per diluted share related to the U.S. government's COVID-19 vaccine distribution and kitting programs

IRVING, Texas, August 4, 2021 -
McKesson Corporation (NYSE:MCK) today reported results for the first quarter ended June 30, 2021.

Fiscal 2022 First-Quarter Result Summary
First-Quarter
($ in millions, except per share amounts)FY22FY21Change
Revenues$62,674 $55,679 13 %
Income (loss) from Continuing Operations1
489 445 10 
Adjusted Earnings1,2
880 453 94 
Earnings (loss) per Diluted Share1
3.09 2.72 14 
Adjusted Earnings per Diluted Share1,2
5.56 2.77 101 
1Reflects continuing operations attributable to McKesson, net of tax
2Represents a non-GAAP financial measure; refer to the reconciliations of non-GAAP financial measures included in accompanying schedules

"McKesson delivered record first-quarter earnings, marking another quarter of solid performance across all four operating segments,” said Brian Tyler, chief executive officer. “As we execute against our strategic priorities, we are evolving our portfolio to drive long-term growth and create shareholder value. We remain optimistic that the momentum we’ve generated will continue given the strength we see across our businesses. Based on our first-quarter operating performance and current trends, we are raising our previous guidance range for fiscal 2022 Adjusted Earnings per diluted share to $19.80 to $20.40.”

First-quarter revenues were $62.7 billion, an increase of 13% from a year ago, driven by growth in the U.S. Pharmaceutical segment, largely due to higher volumes from retail national account customers and market growth, partially offset by branded to generic conversions.


The following information was filed by Mckesson Corp (MCK) on Wednesday, August 4, 2021 as an 8K 2.02 statement, which is an earnings press release pertaining to results of operations and financial condition. It may be helpful to assess the quality of management by comparing the information in the press release to the information in the accompanying 10-Q Quarterly Report statement of earnings and operation as management may choose to highlight particular information in the press release.

View differences made from one quarter to another to evaluate Mckesson Corp's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-Q Quarterly Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Mckesson Corp.

Continue

Assess how Mckesson Corp's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Mckesson Corp's Definitive Proxy Statement (Form DEF 14A) filed after their 2021 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools

Rating

Learn More
Bullish Bearish Neutral
Filter Sentiment:
All
Positive
Negative
Filter Category:
All
Financial
Revenue
Legal
Other
Filter Subcategory:
All
Expense
Cash Flow
Product
Income
Debt
Earnings
Shares
Geography
Other
Inside Mckesson Corp's 10-Q Quarterly Report:

Financial Statements, Disclosures and Schedules

Inside this 10-Q Quarterly Report

Cover Page
Condensed Consolidated Balance Sheets
Condensed Consolidated Balance Sheets (Parenthetical)
Condensed Consolidated Statements Of Cash Flows
Condensed Consolidated Statements Of Comprehensive Income (Loss)
Condensed Consolidated Statements Of Operations
Condensed Consolidated Statements Of Stockholders' Equity (Deficit)
Condensed Consolidated Statements Of Stockholders' Equity (Deficit) (Parenthetical)
Commitments And Contingent Liabilities
Commitments And Contingent Liabilities (Tables)
Commitments And Contingent Liabilities - Estimated Accrual Liability (Details)
Commitments And Contingent Liabilities - Narrative (Details)
Debt And Financing Activities
Debt And Financing Activities (Tables)
Debt And Financing Activities - Commercial Paper (Details)
Debt And Financing Activities - Long-Term Debt Narrative (Details)
Debt And Financing Activities - Revolving Credit Facilities (Details)
Debt And Financing Activities - Schedule Of Long-Term Debt (Details)
Earnings (Loss) Per Common Share
Earnings (Loss) Per Common Share (Details)
Earnings (Loss) Per Common Share (Tables)
Fair Value Measurements
Fair Value Measurements (Details)
Fair Value Measurements (Tables)
Goodwill And Intangible Assets, Net
Goodwill And Intangible Assets, Net (Tables)
Goodwill And Intangible Assets, Net - Narrative - Intangible Assets (Details)
Goodwill And Intangible Assets, Net - Schedule Of Changes In The Carrying Amount Of Goodwill (Details)
Goodwill And Intangible Assets, Net - Schedule Of Information Regarding Intangible Assets (Details)
Hedging Activities
Hedging Activities (Tables)
Hedging Activities - Derivative Instruments Fair Value (Details)
Hedging Activities - Narrative (Details)
Held For Sale
Held For Sale - Narrative (Details)
Income Taxes
Income Taxes (Details)
Pension Benefits
Pension Benefits - Narrative (Details)
Redeemable Noncontrolling Interests And Noncontrolling Interests
Redeemable Noncontrolling Interests And Noncontrolling Interests (Tables)
Redeemable Noncontrolling Interests And Noncontrolling Interests - Narrative (Details)
Redeemable Noncontrolling Interests And Noncontrolling Interests - Schedule Of Changes In Redeemable Noncontrolling Interests And Noncontrolling Interests (Details)
Restructuring, Impairment, And Related Charges
Restructuring, Impairment, And Related Charges (Tables)
Restructuring, Impairment, And Related Charges - Narrative (Details)
Restructuring, Impairment, And Related Charges - Summary Of Restructuring Activity (Details)
Restructuring, Impairment, And Related Charges - Summary Of Restructuring Charges (Details)
Segments Of Business
Segments Of Business (Details)
Segments Of Business (Tables)
Significant Accounting Policies
Significant Accounting Policies (Policies)
Significant Accounting Policies - Narrative (Details)
Stockholders' Equity (Deficit)
Stockholders' Equity (Deficit) (Tables)
Stockholders' Equity (Deficit) - Narrative (Details)
Stockholders' Equity (Deficit) - Schedule Of Changes In Accumulated Other Comprehensive Income (Loss) By Component (Details)
Stockholders' Equity (Deficit) - Schedule Of Other Comprehensive Income (Loss), Net Of Tax (Details)

Material Contracts, Statements, Certifications & more

Mckesson Corp provided additional information to their SEC Filing as exhibits

Ticker: MCK
CIK: 927653
Form Type: 10-Q Quarterly Report
Accession Number: 0000927653-21-000065
Submitted to the SEC: Wed Aug 04 2021 5:44:11 PM EST
Accepted by the SEC: Thu Aug 05 2021
Period: Wednesday, June 30, 2021
Industry: Wholesale Drugs Proprietaries And Druggists Sundries

External Resources:
Stock Quote
Social Media

Bookmark the Permalink:
https://last10k.com/sec-filings/mck/0000927653-21-000065.htm